Summary
- Current Price
- As of today, KLRS price is $5.79, down -2.44% on
- Current Price All-Time High
- KLRS price is currently -99.49% below its historical high of $1,126.08 set on
- Market Cap
- KLRS current market cap is $108M, down -28.25% year-over-year
- PE Ratio
- KLRS PE ratio is unknown
- Revenue
- KLRS current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for KLRS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Kalaris Therapeutics, Inc. |
| Ticker | NASDAQ: KLRS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kalaristx.com |
| Employees | 14 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.79 | ||
| Price, 1D Change | -2.44% | |
| $108M | ||
| - | ||
| - | ||
| 0.89 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.85 | ||
| EPS, 1Y Change | +94.50% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:23 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ALVR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.85 | ||
| EPS Estimate | N/A | -$2.26 |
| EPS Est. Change | N/A | +20.74% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $5.79 | ||
| Price Target | - | $21.50 |
| Price Tgt. Change | - | +271.33% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.70 | -$2.85 | +23.04% | |
| -$2.26 | N/A | +20.74% | |
| -$1.45 | N/A | +48.92% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| $13.33M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -28.25% | ||
| -93.61% | ||
| -28.25% | ||
| -70.58% | ||
| 0.00% | ||
| 0.00% | ||
| +94.50% | ||
| +94.38% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $5.79 | ||
| $5.98 | ||
| SMA 200 vs Price | +3.34% | |
| $8.72 | ||
| SMA 50 vs Price | +50.62% | |
| 0.89 | ||
| $0.75 | ||
| 31.00 | ||
| 72.40% | ||
| 112.76% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.85 | ||
| $0.00 | ||
| - | ||
| -$46.15M | ||
| - | ||
| -$43.44M | ||
| - | ||
| -$46.14M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 12.23 | ||
| 12.23 | ||
| - | ||
| - | ||
| -0.50 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.37 | ||
| 0.18 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $78.81M | ||
| $117.98M | ||
| $121.74M | ||
| $118.81M | ||
| $42.92M | ||
| $9.71M | ||
| $1.45M | ||
| $316.00K | ||
| $1.28M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $43.44M | ||
| $46.15M | ||
| $13.00K | ||
| $0.00 | ||
| $13.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$42.98M | ||
| -$19.72M | ||
| $159.61M | ||
| $200.00K | ||
| -$43.18M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Chardan Capital | ||
| Citizens | ||
| Raymond James | ||
| William Blair |
Analyst sentiment
Institutional ownership
Screeners with KLRS
FAQ
What is the ticker symbol for Kalaris Therapeutics, Inc.?
The ticker symbol for Kalaris Therapeutics, Inc. is NASDAQ:KLRS
Does Kalaris Therapeutics, Inc. pay dividends?
No, Kalaris Therapeutics, Inc. does not pay dividends
What sector is Kalaris Therapeutics, Inc. in?
Kalaris Therapeutics, Inc. is in the Healthcare sector
What industry is Kalaris Therapeutics, Inc. in?
Kalaris Therapeutics, Inc. is in the Biotechnology industry
What country is Kalaris Therapeutics, Inc. based in?
Kalaris Therapeutics, Inc. is headquartered in United States
When did Kalaris Therapeutics, Inc. go public?
Kalaris Therapeutics, Inc. initial public offering (IPO) was on July 30, 2020
Is Kalaris Therapeutics, Inc. in the S&P 500?
No, Kalaris Therapeutics, Inc. is not included in the S&P 500 index
Is Kalaris Therapeutics, Inc. in the NASDAQ 100?
No, Kalaris Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Kalaris Therapeutics, Inc. in the Dow Jones?
No, Kalaris Therapeutics, Inc. is not included in the Dow Jones index
When was Kalaris Therapeutics, Inc. last earnings report?
Kalaris Therapeutics, Inc.'s most recent earnings report was on August 7, 2025
When does Kalaris Therapeutics, Inc. report earnings?
The date for Kalaris Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- KLRS Official Website kalaristx.com
- KLRS Profile on Yahoo Finance finance.yahoo.com/quote/KLRS
- KLRS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/klrs